{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:02:16Z","timestamp":1784847736734,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11513-4","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T08:49:06Z","timestamp":1743756546000},"page":"7004-7012","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["External validation of inter-reader reliability of the Prostate Imaging after Focal Ablation (PI-FAB) scoring system following focal cryoablation and focal high-intensity focused ultrasound"],"prefix":"10.1007","volume":"35","author":[{"given":"Michael C.","family":"Ivey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram","family":"Deivasigamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinath","family":"Kotamarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Mottaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Ghoreifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Jhaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary N.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle E.","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Kalisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah P.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Polascik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2984-5010","authenticated-orcid":false,"given":"Rajan T.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"11513_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/JU.0000000000002854","volume":"208","author":"JA Eastham","year":"2022","unstructured":"Eastham JA, Boorjian SA, Kirkby E (2022) Clinically localized prostate cancer: AUA\/ASTRO Guideline. J Urol 208:505\u2013507","journal-title":"J Urol"},{"key":"11513_CR2","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jama.2017.1652","volume":"317","author":"RC Chen","year":"2017","unstructured":"Chen RC, Basak R, Meyer AM et al (2017) Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer. JAMA 317:1141\u20131150","journal-title":"JAMA"},{"key":"11513_CR3","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1089\/end.2020.0740","volume":"35","author":"WP Tan","year":"2021","unstructured":"Tan WP, Chang A, Sze C, Polascik TJ (2021) Oncological and functional outcomes of patients undergoing individualized partial gland cryoablation of the prostate: a single-institution experience. J Endourol 35:1290\u20131299","journal-title":"J Endourol"},{"key":"11513_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.eururo.2022.01.005","volume":"81","author":"D Reddy","year":"2022","unstructured":"Reddy D, Peters M, Shah TT et al (2022) Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15-year experience. Eur Urol 81:407\u2013413","journal-title":"Eur Urol"},{"key":"11513_CR5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389:815\u2013822","journal-title":"Lancet"},{"key":"11513_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.eururo.2020.05.018","volume":"78","author":"AH Lebastchi","year":"2020","unstructured":"Lebastchi AH, George AK, Polascik TJ et al (2020) Standardized nomenclature and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer: an international multidisciplinary consensus. Eur Urol 78:371\u2013378","journal-title":"Eur Urol"},{"key":"11513_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 76:340\u2013351","journal-title":"Eur Urol"},{"key":"11513_CR8","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.euo.2021.01.003","volume":"4","author":"V Panebianco","year":"2021","unstructured":"Panebianco V, Villeirs G, Weinreb JC et al (2021) Prostate magnetic resonance imaging for local recurrence reporting (PI-RR): international consensus -based guidelines on multiparametric magnetic resonance imaging for prostate cancer recurrence after radiation therapy and radical prostatectomy. Eur Urol Oncol 4:868\u2013876","journal-title":"Eur Urol Oncol"},{"key":"11513_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.euo.2023.04.007","volume":"6","author":"F Giganti","year":"2023","unstructured":"Giganti F, Dickinson L, Orczyk C et al (2023) Prostate imaging after focal ablation (PI-FAB): a proposal for a scoring system for multiparametric mri of the prostate after focal therapy. Eur Urol Oncol 6:629\u2013634","journal-title":"Eur Urol Oncol"},{"key":"11513_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00345-018-2363-y","volume":"37","author":"KJ Tay","year":"2019","unstructured":"Tay KJ, Amin MB, Ghai S et al (2019) Surveillance after prostate focal therapy. World J Urol 37:397\u2013407","journal-title":"World J Urol"},{"key":"11513_CR11","first-page":"317","volume":"69","author":"KJ Tay","year":"2016","unstructured":"Tay KJ, Polascik TJ (2016) Focal cryotherapy for localized prostate cancer. Arch Esp Urol 69:317\u2013326","journal-title":"Arch Esp Urol"},{"key":"11513_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","volume":"69","author":"JC Weinreb","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS Prostate Imaging\u2014Reporting and Data System: 2015, Version 2. Eur Urol 69:16\u201340","journal-title":"Eur Urol"},{"key":"11513_CR13","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.euo.2020.06.007","volume":"3","author":"F Giganti","year":"2020","unstructured":"Giganti F, Allen C, Emberton M, Moore CM, Kasivisvanathan V, PRECISION Study Group (2020) Prostate Imaging Quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial. Eur Urol Oncol 3:615\u2013619","journal-title":"Eur Urol Oncol"},{"key":"11513_CR14","doi-asserted-by":"publisher","unstructured":"de Rooij M, Allen C, Twilt JJ et al (2024) PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-024-10795-4","DOI":"10.1007\/s00330-024-10795-4"},{"key":"11513_CR15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1910038","volume":"382","author":"M Ahdoot","year":"2020","unstructured":"Ahdoot M, Wilbur AR, Reese SE et al (2020) MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis. N Engl J Med 382:917\u2013928","journal-title":"N Engl J Med"},{"key":"11513_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.eururo.2013.05.059","volume":"64","author":"MM Siddiqui","year":"2013","unstructured":"Siddiqui MM, Rais-Bahrami S, Truong H et al (2013) Magnetic resonance imaging\/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 64:713\u2013719","journal-title":"Eur Urol"},{"key":"11513_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.2014.17942","volume":"313","author":"MM Siddiqui","year":"2015","unstructured":"Siddiqui MM, Rais-Bahrami S, Turkbey B et al (2015) Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313:390\u2013397","journal-title":"JAMA"},{"key":"11513_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1148\/radiol.2020190646","volume":"296","author":"AC Westphalen","year":"2020","unstructured":"Westphalen AC, McCulloch CE, Anaokar JM et al (2020) Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology 296:76\u201384","journal-title":"Radiology"},{"key":"11513_CR19","doi-asserted-by":"publisher","unstructured":"Englman C, Maffei D, Allen C et al (2024) PRECISE Version 2: Updated recommendations for reporting prostate magnetic resonance imaging in patients on active surveillance for prostate cancer. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.014","DOI":"10.1016\/j.eururo.2024.03.014"},{"key":"11513_CR20","doi-asserted-by":"publisher","first-page":"852","DOI":"10.2214\/AJR.22.28665","volume":"220","author":"J Abreu-Gomez","year":"2023","unstructured":"Abreu-Gomez J, Dias AB, Ghai S (2023) PI-RR: The prostate imaging for recurrence reporting system for MRI assessment of local prostate cancer recurrence after radiation therapy or radical prostatectomy-a review. AJR Am J Roentgenol 220:852\u2013861","journal-title":"AJR Am J Roentgenol"},{"key":"11513_CR21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/JU.0000000000003569","volume":"210","author":"JS Wysock","year":"2023","unstructured":"Wysock JS, Rapoport E, Hernandez H, Gogaj R, Lepor H (2023) Biopsy assessment of oncologic control 3 years following primary partial gland cryoablation: a prospective cohort study of men with intermediate-risk prostate cancer. J Urol 210:454\u2013464","journal-title":"J Urol"},{"key":"11513_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.prnil.2022.12.004","volume":"11","author":"H Ahn","year":"2023","unstructured":"Ahn H, Hwang SI, Lee HJ et al (2023) Diagnostic performance of MRI for prediction of recurrent prostate cancer after high-intensity focused ultrasound: a systematic review and meta-analysis. Prostate Int 11:59\u201368","journal-title":"Prostate Int"},{"key":"11513_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2024.111463","volume":"175","author":"AM Pausch","year":"2024","unstructured":"Pausch AM, Elsner C, Rupp NJ, Eberli D, Hotker AM (2024) MRI-based monitoring of prostate cancer after HIFU: Inter-reader agreement and diagnostic performance of the PI-FAB score. Eur J Radiol 175:111463","journal-title":"Eur J Radiol"},{"key":"11513_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.euros.2024.02.012","volume":"62","author":"DG Gelikman","year":"2024","unstructured":"Gelikman DG, Kenigsberg AP, Mee Law Y et al (2024) Evaluating Diagnostic Accuracy and Inter-reader Agreement of the Prostate Imaging After Focal Ablation Scoring System. Eur Urol Open Sci 62:74\u201380","journal-title":"Eur Urol Open Sci"},{"key":"11513_CR25","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2024.02.001","volume":"85","author":"A Light","year":"2024","unstructured":"Light A, Mayor N, Cullen E et al (2024) The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations. Eur Urol 85:466\u2013482","journal-title":"Eur Urol"},{"key":"11513_CR26","doi-asserted-by":"publisher","unstructured":"Esengur OT, Gelikman DG, Law YM et al (2024) Comparison of Transatlantic Recommendations for Prostate Gland Evaluation with MRI after Focal Therapy (TARGET) and Prostate Imaging after Focal Ablation (PI-FAB) for Detecting Recurrent Prostate Cancer at Prostate MRI. Acad Radiol. https:\/\/doi.org\/10.1016\/j.acra.2024.09.051","DOI":"10.1016\/j.acra.2024.09.051"},{"key":"11513_CR27","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1007\/s00261-024-04506-2","volume":"49","author":"R Girometti","year":"2024","unstructured":"Girometti R, Peruzzi V, Polizzi P et al (2024) Case-by-case combination of the prostate imaging reporting and data system version 2.1 with the Likert score to reduce the false-positives of prostate MRI: a proof-of-concept study. Abdom Radiol (NY) 49:4273\u20134285","journal-title":"Abdom Radiol (NY)"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11513-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11513-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11513-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:02:12Z","timestamp":1761627732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11513-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["11513"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11513-4","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Rajan T. Gupta.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relevant relationships with any companies, whose products or services may be related to the subject matter of the article. Unrelated to this work, Dr. Gupta reports consulting fees from Bard, Bayer Pharma AG, Bracco Diagnostics, Philips, and Quibim.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No study subjects or cohorts have been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}